Figure 1.

(A) Swimmer plot of patients who received nivolumab. Each lane represents an individual patient’s tumor type, best objective response, sex, age, and treatment duration. (B) Progression-free survival of patients based on the RECIST criteria response. PR, partial response; RECIST, Response Evaluation Criteria in Solid Tumors; SD, stable disease.